These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11193158)

  • 1. Alpha 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo.
    Abraham CR; McGraw WT; Slot F; Yamin R
    Ann N Y Acad Sci; 2000; 920():245-8. PubMed ID: 11193158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-beta peptide degradation.
    Yamin R; Malgeri EG; Sloane JA; McGraw WT; Abraham CR
    J Biol Chem; 1999 Jun; 274(26):18777-84. PubMed ID: 10373494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach for studying endogenous abeta processing using cultured primary neurons isolated from APP transgenic mice.
    Qiu Z; Naten DL; Liston JC; Yess J; Rebeck GW
    Exp Neurol; 2001 Jul; 170(1):186-94. PubMed ID: 11421596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
    Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
    J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
    Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
    Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease.
    Yu WH; Kumar A; Peterhoff C; Shapiro Kulnane L; Uchiyama Y; Lamb BT; Cuervo AM; Nixon RA
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2531-40. PubMed ID: 15325590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular pathways of folded and misfolded amyloid precursor protein degradation.
    Hare JF
    Arch Biochem Biophys; 2006 Jul; 451(1):79-90. PubMed ID: 16764819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic regulation of mouse muscle beta-amyloid protein precursor and alpha 1-antichymotrypsin as revealed by axotomy.
    Akaaboune M; Ma J; Festoff BW; Greenberg BD; Hantaï D
    J Neurobiol; 1994 May; 25(5):503-14. PubMed ID: 8071658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.
    Tan J; Town T; Crawford F; Mori T; DelleDonne A; Crescentini R; Obregon D; Flavell RA; Mullan MJ
    Nat Neurosci; 2002 Dec; 5(12):1288-93. PubMed ID: 12402041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine proteinase inhibitors in human skeletal muscle: expression of beta-amyloid protein precursor and alpha 1-antichymotrypsin in vivo and during myogenesis in vitro.
    Akaaboune M; Verdière-Sahuqué M; Lachkar S; Festoff BW; Hantaï D
    J Cell Physiol; 1995 Dec; 165(3):503-11. PubMed ID: 7593229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation.
    Nilsson LN; Arendash GW; Leighty RE; Costa DA; Low MA; Garcia MF; Cracciolo JR; Rojiani A; Wu X; Bales KR; Paul SM; Potter H
    Neurobiol Aging; 2004 Oct; 25(9):1153-67. PubMed ID: 15312961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
    Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.